rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Leana Wen

Director

Company insider

Files Form 4 as: Director, Glaukos; Director, UroGen Pharma.

Every Form 4 they filed

In numbers

Trades disclosed
36
Buys
0
Sells
2
Bought
$0
Sold
$663K
Companies
2
Companies where not an officer
2
First trade
1 Mar 2021
Last trade
31 Jul 2026
Last filed
3 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
GKOS GlaukosDirector · Medical Devices · last 31 Jul 20260 buys · 2 sells
URGN UroGen PharmaDirector · Biotechnology · last 22 Jun 20260 buys · 0 sells

Activity over time

1 Apr – 1 Oct
10Apr 26Jun 26Jul 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
31 Jul 2026filed 3 Aug 2026GKOS GlaukosMedical DevicesSEC FORM 4 Sold$88K525 at $167.63filing
31 Jul 2026filed 3 Aug 2026GKOS GlaukosMedical DevicesSEC FORM 4 Sold$88K525 at $167.63filing
22 Jun 2026filed 24 Jun 2026URGN UroGen Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
22 Jun 2026filed 24 Jun 2026URGN UroGen Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—8,000 at $0.00filing
22 Jun 2026filed 24 Jun 2026URGN UroGen Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
22 Jun 2026filed 24 Jun 2026URGN UroGen Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—8,000 at $0.00filing
28 May 2026filed 23 Jun 2026GKOS Glaukosoption or derivative · Medical DevicesSEC FORM 4 Code A—2,987 at $0.00filing
28 May 2026filed 23 Jun 2026GKOS Glaukosoption or derivative · Medical DevicesSEC FORM 4 Code A—2,987 at $0.00filing
28 May 2026filed 1 Jun 2026GKOS GlaukosMedical DevicesSEC FORM 4 Code A—1,878 at $0.00filing
28 May 2026filed 1 Jun 2026GKOS Glaukosoption or derivative · Medical DevicesSEC FORM 4 Code A—2,987 at $0.00filing
28 May 2026filed 1 Jun 2026GKOS Glaukosoption or derivative · Medical DevicesSEC FORM 4 Code A—2,987 at $0.00filing
28 May 2026filed 1 Jun 2026GKOS GlaukosMedical DevicesSEC FORM 4 Code A—1,878 at $0.00filing
1 May 2026filed 4 May 2026GKOS GlaukosMedical DevicesSEC FORM 4 Sold$244K1,700 at $143.35filing
1 May 2026filed 4 May 2026GKOS GlaukosMedical DevicesSEC FORM 4 Sold$244K1,700 at $143.35filing
2 Jan 2026filed 7 Jan 2026GKOS GlaukosMedical DevicesSEC FORM 4 Code A—623 at $0.00filing
2 Jan 2026filed 7 Jan 2026GKOS GlaukosMedical DevicesSEC FORM 4 Code A—623 at $0.00filing
26 Nov 2025filed 1 Dec 2025URGN UroGen Pharmaoption or derivative · BiotechnologySEC FORM 4 Code M—2,000 at $0.00filing
26 Nov 2025filed 1 Dec 2025URGN UroGen PharmaBiotechnologySEC FORM 4 Code M—2,000filing
26 Aug 2025filed 27 Aug 2025URGN UroGen Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
26 Aug 2025filed 27 Aug 2025URGN UroGen Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—8,000 at $0.00filing

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Chris DegnanChief Financial Officer · Chief Financial Officer at UroGen Pharma, filing Form 4 there in the last year
Tomas NavratilChief Development Officer · Chief Development Officer at Glaukos, filing Form 4 there in the last year
Mark SchoenbergChief Medical Officer · Chief Medical Officer at UroGen Pharma, filing Form 4 there in the last year
Jason Drew SmithGeneral Counsel · General Counsel at UroGen Pharma, filing Form 4 there in the last year
James A. Robinson Jr.Director · Director at UroGen Pharma, filing Form 4 there in the last year
Gilbert H. KlimanDirector · Also traded GKOS in the last 90 days
Joseph E. GilliamDirector · Also traded GKOS in the last 90 days
Alex R. ThurmanSVP & Chief Financial Officer · Also traded GKOS in the last 90 days